> The Food and Drug Administration approves new cancer treatments when they are shown in clinical trials to be more effective than the current approved cancer treatment for a given cancer type. The approval comes when the treatment extends lifespan without overly increasing the risks of serious side effects.

This standard just doesn’t make sense to me. Every case is different, so why “throw out” a treatment option for only being within the margin of error of efficacy on a general population? It must be incredibly frustrating for patients to know about these treatments…